Ecnoglutide vs Exenatide

Ecnoglutide is an experimental GLP-1 receptor agonist still in development, with no FDA approvals yet. Exenatide, available as Byetta and Bydureon, is an approved GLP-1 receptor agonist used to treat type 2 diabetes. The main difference is that Ecnoglutide is not yet on the market, while Exenatide has been approved and is sold by different makers under two brand names.

AI summary of the sources below.